Limits...
Itk negatively regulates induction of T cell proliferation by CD28 costimulation.

Liao XC, Fournier S, Killeen N, Weiss A, Allison JP, Littman DR - J. Exp. Med. (1997)

Bottom Line: T cells defective in Itk were found to be fully competent to respond to costimulation.Whereas the CD3-mediated proliferative response was severely compromised in the absence of Itk, the calcineurin-independent CD28-mediated response was significantly elevated when compared with cells from control animals.The results suggest that Itk has distinct roles in the CD3 versus the CD28 signaling pathways.

View Article: PubMed Central - PubMed

Affiliation: Department of Microbiology and Immunology, University of California, San Francisco, California 94143, USA.

ABSTRACT
CD28 is a cell surface molecule that mediates a costimulatory signal crucial for T cell proliferation and lymphokine production. The signal transduction mechanisms of CD28 are not well understood. Itk, a nonreceptor protein tyrosine kinase specifically expressed in T cells and mast cells, has been implicated in the CD28 signaling pathway because of reports that it becomes phosphorylated on tyrosines and associates with CD28 upon cross-linking of the cell surface molecule. To determine whether Itk plays a functional role in CD28 signaling, we compared T cells from Itk-deficient mice and control mice for their responses to CD28 costimulation. T cells defective in Itk were found to be fully competent to respond to costimulation. Whereas the CD3-mediated proliferative response was severely compromised in the absence of Itk, the calcineurin-independent CD28-mediated response was significantly elevated when compared with cells from control animals. The augmented proliferation was not due to increased production of interleukin-2. The results suggest that Itk has distinct roles in the CD3 versus the CD28 signaling pathways. By negatively regulating the amplitude of signaling upon CD28 costimulation, Itk may provide a means for modulating the outcome of T cell activation during development and during antigen-driven immune responses.

Show MeSH

Related in: MedlinePlus

Cell proliferation induced by  TCR and CD28 is dependent on IL-2.  CD4+ T cells from itk−/− mice and itk+/−  littermates were stimulated with plate-bound  anti-CD3 at different concentrations as indicated, in the presence or absence of anti-CD28 ascites (1:500). Anti-CD28 and anti-murine IL-2 were added with anti-murine  IL-2R or with recombinant human IL-2 at  the beginning of culture. Cell proliferation  was measured 72 h after stimulation.  a-CD28, anti-CD28 ascites; a-mIL2, anti-murine IL-2 mAb; a-mIL2R, anti-murine  IL-2Rα mAb; and hIL-2, recombinant human IL-2.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2198978&req=5

Figure 4: Cell proliferation induced by TCR and CD28 is dependent on IL-2. CD4+ T cells from itk−/− mice and itk+/− littermates were stimulated with plate-bound anti-CD3 at different concentrations as indicated, in the presence or absence of anti-CD28 ascites (1:500). Anti-CD28 and anti-murine IL-2 were added with anti-murine IL-2R or with recombinant human IL-2 at the beginning of culture. Cell proliferation was measured 72 h after stimulation. a-CD28, anti-CD28 ascites; a-mIL2, anti-murine IL-2 mAb; a-mIL2R, anti-murine IL-2Rα mAb; and hIL-2, recombinant human IL-2.

Mentions: Monoclonal antibodies used for immunofluorescence staining have been described (27). Antibodies used for cell purification include anti-HSA (M1/69), anti-CD8α (53-6.72 and 3.155), anti-I-Ab,d (28-16-8S), anti-I-Ab,d,  j,p,q,u (BP107), anti-rat immunoglobulins, and anti-mouse immunoglobulins (American Type Culture Collection, Rockville, MD). Antibodies used in cell culture include anti-CD3 (500A2 for Figs. 1, 2, 4, and 145-2C11 for Fig. 3), anti-CD28 (37.51), anti-CTLA-4 (9H10), anti-IL-2 (S4B6), anti-IL-2Rα (3C7), and anti-IL-4 (11B11) (PharMingen, San Diego, CA). Antibodies used in the IL-2 ELISA include the capture mAb JES6-1A12 and the detecting mAb JES6-5H4 (PharMingen, San Diego, CA).


Itk negatively regulates induction of T cell proliferation by CD28 costimulation.

Liao XC, Fournier S, Killeen N, Weiss A, Allison JP, Littman DR - J. Exp. Med. (1997)

Cell proliferation induced by  TCR and CD28 is dependent on IL-2.  CD4+ T cells from itk−/− mice and itk+/−  littermates were stimulated with plate-bound  anti-CD3 at different concentrations as indicated, in the presence or absence of anti-CD28 ascites (1:500). Anti-CD28 and anti-murine IL-2 were added with anti-murine  IL-2R or with recombinant human IL-2 at  the beginning of culture. Cell proliferation  was measured 72 h after stimulation.  a-CD28, anti-CD28 ascites; a-mIL2, anti-murine IL-2 mAb; a-mIL2R, anti-murine  IL-2Rα mAb; and hIL-2, recombinant human IL-2.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2198978&req=5

Figure 4: Cell proliferation induced by TCR and CD28 is dependent on IL-2. CD4+ T cells from itk−/− mice and itk+/− littermates were stimulated with plate-bound anti-CD3 at different concentrations as indicated, in the presence or absence of anti-CD28 ascites (1:500). Anti-CD28 and anti-murine IL-2 were added with anti-murine IL-2R or with recombinant human IL-2 at the beginning of culture. Cell proliferation was measured 72 h after stimulation. a-CD28, anti-CD28 ascites; a-mIL2, anti-murine IL-2 mAb; a-mIL2R, anti-murine IL-2Rα mAb; and hIL-2, recombinant human IL-2.
Mentions: Monoclonal antibodies used for immunofluorescence staining have been described (27). Antibodies used for cell purification include anti-HSA (M1/69), anti-CD8α (53-6.72 and 3.155), anti-I-Ab,d (28-16-8S), anti-I-Ab,d,  j,p,q,u (BP107), anti-rat immunoglobulins, and anti-mouse immunoglobulins (American Type Culture Collection, Rockville, MD). Antibodies used in cell culture include anti-CD3 (500A2 for Figs. 1, 2, 4, and 145-2C11 for Fig. 3), anti-CD28 (37.51), anti-CTLA-4 (9H10), anti-IL-2 (S4B6), anti-IL-2Rα (3C7), and anti-IL-4 (11B11) (PharMingen, San Diego, CA). Antibodies used in the IL-2 ELISA include the capture mAb JES6-1A12 and the detecting mAb JES6-5H4 (PharMingen, San Diego, CA).

Bottom Line: T cells defective in Itk were found to be fully competent to respond to costimulation.Whereas the CD3-mediated proliferative response was severely compromised in the absence of Itk, the calcineurin-independent CD28-mediated response was significantly elevated when compared with cells from control animals.The results suggest that Itk has distinct roles in the CD3 versus the CD28 signaling pathways.

View Article: PubMed Central - PubMed

Affiliation: Department of Microbiology and Immunology, University of California, San Francisco, California 94143, USA.

ABSTRACT
CD28 is a cell surface molecule that mediates a costimulatory signal crucial for T cell proliferation and lymphokine production. The signal transduction mechanisms of CD28 are not well understood. Itk, a nonreceptor protein tyrosine kinase specifically expressed in T cells and mast cells, has been implicated in the CD28 signaling pathway because of reports that it becomes phosphorylated on tyrosines and associates with CD28 upon cross-linking of the cell surface molecule. To determine whether Itk plays a functional role in CD28 signaling, we compared T cells from Itk-deficient mice and control mice for their responses to CD28 costimulation. T cells defective in Itk were found to be fully competent to respond to costimulation. Whereas the CD3-mediated proliferative response was severely compromised in the absence of Itk, the calcineurin-independent CD28-mediated response was significantly elevated when compared with cells from control animals. The augmented proliferation was not due to increased production of interleukin-2. The results suggest that Itk has distinct roles in the CD3 versus the CD28 signaling pathways. By negatively regulating the amplitude of signaling upon CD28 costimulation, Itk may provide a means for modulating the outcome of T cell activation during development and during antigen-driven immune responses.

Show MeSH
Related in: MedlinePlus